More on CGEN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.99 |
|
|||
| Open | $2.05 | ||||
| 52 Wk High | $7.79 | ||||
| 52 Wk Low | $4.32 | ||||
| Day High | $2.04 | ||||
| Day Low | $1.96 | ||||
| P/E | N/A | ||||
| EPS | $-0.36 | ||||
| Volume | 503,835 | ||||
- Compugen presents COM701 ovarian cancer trial poster at ESMO
- Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
- Compugen to present ovarian cancer trial data at ESMO congress
- Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026
- Form EFFECT COMPUGEN LTD
- Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development
- H.C. Wainwright Reiterates Buy Rating on Compugen (CGEN)
- Form F-3 COMPUGEN LTD
- Compugen (CGEN) Misses Q1 EPS by 1c
- Form 6-K COMPUGEN LTD For: May 18
Entities mentioned with CGEN
- Earnings | View Related Stories »
- FDA | View Related Stories »
- 13G | View Related Stories »
- Stifel | View Related Stories »
- Jefferies & Co | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- JMP Securities | View Related Stories »
- Show More...
